Forward stepwise logistic regression analyses were used to measure the influence of CD2, CD34, and CD56 expression and WBC count before treatment on the incidence of DS, early death, remission failure, five-year OS, and five-year relapse. The gene discussed is CD2; the disease is Dravet syndrome.